Vandetanib

Back to search
Scientific Name: Vandetanib
Brand Name: Caprelsa
Company Owner: Not Available
Mechanism Of Action ZD-6474 is a potent and selective inhibitor of VEGFR (vascular endothelial growth factor receptor) , EGFR (epidermal growth factor receptor) and RET (REarranged during Transfection) tyrosine kinases.
Description of the Drug: Vandetanib is an antineoplastic kinase inhibitor used to treat symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
Protein Data Bank:
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB05294